Renaissance Technologies - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 33 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$909,000
-40.7%
1,463,810
-7.4%
0.00%0.0%
Q1 2019$1,533,000
+25.0%
1,580,610
+1.6%
0.00%0.0%
Q4 2018$1,226,000
-29.1%
1,555,410
+16.9%
0.00%
-50.0%
Q3 2018$1,730,000
-49.0%
1,331,100
-49.1%
0.00%0.0%
Q2 2018$3,394,000
+82.6%
2,615,400
+92.7%
0.00%0.0%
Q1 2018$1,859,000
-9.0%
1,356,900
-8.3%
0.00%0.0%
Q4 2017$2,043,000
-14.1%
1,480,300
-6.0%
0.00%
-33.3%
Q3 2017$2,379,000
+19.1%
1,575,500
+0.9%
0.00%0.0%
Q2 2017$1,998,000
+4.6%
1,561,300
+0.5%
0.00%0.0%
Q1 2017$1,911,000
-6.2%
1,553,800
+9.1%
0.00%0.0%
Q4 2016$2,037,000
-2.9%
1,424,800
+8.6%
0.00%
-25.0%
Q3 2016$2,098,000
+37.1%
1,311,500
+14.0%
0.00%
+33.3%
Q2 2016$1,530,000
-5.6%
1,150,400
+14.3%
0.00%0.0%
Q1 2016$1,621,000
+20.9%
1,006,800
-15.2%
0.00%0.0%
Q4 2015$1,341,000
+91.8%
1,187,048
+209.3%
0.00%
+50.0%
Q3 2015$699,000
-9.8%
383,800
+24.7%
0.00%0.0%
Q2 2015$775,000
+2.6%
307,700
+14.0%
0.00%0.0%
Q1 2015$755,000
+41.4%
269,800
+26.2%
0.00%
+100.0%
Q4 2014$534,000
+214.1%
213,713
+259.8%
0.00%
Q3 2014$170,000
+49.1%
59,394
+62.7%
0.00%
Q2 2014$114,00036,5000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ARK Investment Management 767,424$1,051,0000.05%
MENORA MIVTACHIM HOLDINGS LTD. 1,000,000$1,370,0000.04%
Psagot Value Holdings Ltd. 125,867$173,0000.01%
HERITAGE INVESTORS MANAGEMENT CORP 74,878$103,0000.01%
SABBY MANAGEMENT, LLC 55,280$76,0000.01%
Harel Insurance Investments & Financial Services Ltd. 63,700$87,0000.01%
Renaissance Technologies 1,356,900$1,859,0000.00%
A.R.T. Advisors, LLC 19,322$26,0000.00%
Certified Advisory Corp 2,000$2,0000.00%
HighTower Advisors, LLC 78,200$106,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders